Effect of Desmodium gangeticum Extract on Blood Glucose in Rats and on Insulin Secretion in vitro

Abstract

Desmodium gangeticum is widely used in the indigenous system of medicine in India and is reported to contain flavone and isoflavonoid glycosides. It forms the ingredient of many Ayurvedic formulations used for diabetes. The present study was thus aimed at evaluating the insulin secretion and antidiabetic activity of Desmodium gangeticum. Treatment of diabetic rats with aerial parts of D. gangeticum extract (DG, 100 and 250 mg/kg body weight) for 3 weeks showed a significant reduction in blood glucose. D. gangeticum extract caused a significant increase in insulin secretion from MIN6 cells grown as monolayers and as pseudoislets, indicating that the antidiabetic activity may be as a result of increased insulin secretion. It also had a role on the lipid profile of the rats by causing reductions in cholesterol and triglycerides and increasing the HDL significantly (p < 0.05). This works supports the traditional use of D. gangeticum in the treatment of diabetes and this is likely to be due, at least in part, to its stimulation of insulin secretion by pancreatic islet cells.

Key words

Desmodium gangeticun - Papilionaceae - antidiabetic - insulin secretion - lipid profile

References

• 1 Chopra R N, Nayar S L, Chopra I C. Glossary of Indian medicinal plants. New Delhi; Council of Scientific and Industrial Research 1956: 33-5.
• 2 Ghosal S, Bhattacharya S K. Desmodium alkaloids II, Chemical and pharmacological evaluation of D. gangeticum .  Planta Med. 1972;  22 434-40.
• 3 Purushothman K K, Kishore V M, Narayanaswamy V. The structure and stereochemistry of gangetin. A new pterocarpan from Desmodium gangeticum . J Chem Soc (C) 1971: 2420-2.
• 4 Ghosh D, Anandkumar A. Anti-inflammatory and analgesic activities of Gangetin - A pterocarpenoid from Desmodium gangeticum .  Indian J Pharmacol. 1981;  15 391-402.
• 5 Mishra P K, Singh N, Ahmad G, Dube A, Maurya R. Glycolipids and other constituents from Desmodium gangeticum with antileishmanial and immunomodulatory activities.  Bioorg Med Chem Lett. 2005;  15 4543-6.
• 6 Dharmani P, Mishra P K, Maurya P K, Chauhan V S, Palit G. Desmodium gangeticum: A potent anti-ulcer agent.  Indian J Exp Biol. 2005;  43 517-21.
• 7 Rathi A, Rao C V, Ravishankar B, De S, Mehrotra S. Anti-inflammatory and anti-nociceptive activity of water decoction of Desmodium gangeticum .  J Ethnopharmacol. 2004;  95 259-63.
• 8 Govindarajan R, Rastogi S, Vijayakumar M, Rawat A KS, Shirwaikar A, Mehrotra S. et al . Studies on antioxidant activities of Desmodium gangeticum .  Biol Pharm Bull. 2003;  26 1424-7.
• 9 Govindarajan R, Vijayakumar M, Rawat A KS, Shirwaikar A, Mehrotra S, Pushpangadan P. Antioxidant activity of Desmodium gangeticum and its phenolics in arthritic rats.  Acta Pharm. 2006;  55 489-96.
• 10 Turner R A. Screening methods in pharmacology, Vol. 1. New York; Academic Press 1965: 22-41.
• 11 Sasaki T, Matzy S, Sonal A. Effect of acetic acid concentration on the colour reaction in the o-toluidine boric acid method for blood glucose estimation.  Rinsho Kagaku. 1972;  1 346-53.
• 12 Gey G O, Gey M K. The maintenance of human normal cells in continuous culture. Preliminary report: cultivation of mesoblastic tumours and normal cells and notes on methods of cultivation.  Am J Cancer. 1936;  27 45-75.
• 13 Hauge-Evans A C, Squires P E, Belin V D, Roderigo-Milne H, Ramracheya R D, Persaud S J. et al . Role of adenine nucleotides in insulin secretion from MIN6 pseudoislets.  Mol Cell Endocrinol. 2002;  191 167-76.
• 14 Merzouk H, Madani S, Chabane D. Time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with streptozotocin-induced diabetes.  Clin Sci. 2000;  98 21-30.
• 15 Latner A. Clinical Biochemistry. Philadelphia; Saunders 1958: 48.
• 16 Persaud S J. Pancreatic beta-cell lines: their role in beta-cell research and diabetes therapy. In: Latner A, editor Clinical biochemistry. 2nd edition Philadelphia; Saunders Co 1958: 47.
• 17 Chakrabarti S, Biswas T K, Seal T, Rokeya B, Ali L, Khan A K. et al . Antidiabetic activity of Caesalpinia bonducella F. in chronic type 2 diabetic model in Long-Evans rats and evaluation of insulin secretagogue property of its fractions on isolated islets.  J Ethnopharmacol. 2005;  97 117-22.
• 18 Latha M, Pari L, Sitasawad S, Bhonde R. Insulin-secretagogue activity and cytoprotective role of thetraditional antidiabetic plant Scoparia dulcis (Sweet Broomweed).  Life Sci. 2004;  75 2003-14.
• 19 Altura B M, Lum G, Turlapaty P DDMV, Altura B T. Sequential changes in serum glucose, triglycerides and cholesterol in aging of normal and alloxan-diabetic rats.  Experientia. 1981;  37 224-6.
• 20 Swanston-Flat S K, Day C, Bailey C J, Flatt P R. Traditional plant treatment for diabetes: studies in normal and streptozotocin diabetic mice.  Diabetologia. 1990;  33 462-4.
• 21 Chatterjea M N, Shinde R. Text book of medical biochemistry. New Delhi; Jaypee Brothers Medical Publishers 2002: 317.
• 22 Kurian G A, Phillip S, Varghese T. Effect of aqueous extract of the Desmodium gangeticum DC root in the severity of myocardial infarction.  J Ethnopharmacol. 2005;  97 457-61.
• 23 McCarty M F. Nutraceutical resources for diabetes prevention - an update.  Med Hypotheses. 2005;  64 151-8.
• 24 Rodriguez D V, Hadley M. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats.  J Nutr Biochem. 2002;  13 717-26.